February 6, 2018
WASHINGTON -– Georgetown University Medical Center physicians and researchers are available to answer questions about medical topics related to athletes competing in the 2018 Winter Olympic.
January 30, 2018
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
January 29, 2018
A new study published by researchers led by Michael T. Ullman, PhD, professor of neuroscience at Georgetown University School of Medicine, concludes that language is learned in brain systems that are also used for other purposes and even pre-existed humans.
January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies. The work was conducted by a team of researchers co-led by Charles Holmes, MD, MPH, of Georgetown University Medical Center’s Center for Global Health and Quality and Georgetown’s School of Medicine.
January 4, 2018
A team of researchers led by Georgetown Lombardi Comprehensive Cancer Center has published a study that indicates that the most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought.
December 13, 2017
The National Academy of Inventors has named Jeffrey Toretsky, MD, a pediatric oncologist and researcher at Georgetown Lombardi Comprehensive Cancer Center, to its 2017 class of fellows.
December 11, 2017
Consuming soy foods and cruciferous vegetables may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, according to a team of scientists led by Georgetown Lombardi Comprehensive Cancer Center.
December 6, 2017
The USP Quality Institute and Georgetown University Medical Center announce that Matthew Hassett, Ph.D., and Marissa Malchione, M.S., are the inaugural fellows selected for the institutions’ Fellowship in Quality Medical Products.
December 4, 2017
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
November 20, 2017
MedStar Health has named Louis M. Weiner, MD, as director of its MedStar Georgetown Cancer Institute. Weiner will serve in this capacity while also remaining director of Georgetown Lombardi Comprehensive Cancer Center.